Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Respiratory Medicine›Hyaline Membrane Disease

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Hyaline Membrane Disease

Respiratory Medicine · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

A respiratory distress syndrome in newborn infants, usually premature infants with insufficient pulmonary surfactants.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (907 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A respiratory distress syndrome in newborn infants, usually premature infants with insufficient pulmonary surfactants. The disease is characterized by the formation of a hyaline-like membrane lining the terminal respiratory airspaces (pulmonary alveoli) and subsequent collapse of the lung (pulmonary atelectasis).

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Disease, Hyaline Membrane; Diseases, Hyaline Membrane; Hyaline Membrane Diseases.

Where it fits in the MeSH classification

Broader topics
Respiratory Distress Syndrome, Newborn
See also
Hyaline Fibromatosis Syndrome

Related concepts

  • Pulmonary Surfactants
  • Hyaline-
  • Pulmonary Alveoli
  • Pulmonary Atelectasis

Research landscape

PubMed indexes 2,609 records tagged with the MeSH heading “Hyaline Membrane Disease” (counts retrieved 2026-11-04). 21 of them (0.8%) were published from 2020 onward, and the busiest period so far is through 1999 with 2,440 records.

Reviews account for 171 records (6.6%) and meta-analyses for 6. Randomized controlled trials number 49 (1.9%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 2,440 records; 2000-2009: 89 records; 2010-2019: 59 records; 2020 onward: 21 records2,440through 1999892000-2009592010-2019212020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19992,440
2000-200989
2010-201959
2020 onward21
Share of records by publication typeReviews: 6.6 percent; Meta-analyses: 0.2 percent; Randomized controlled trials: 1.9 percentReviews6.6% (171)Meta-analyses0.2% (6)Randomized controlled trials1.9% (49)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 2,609 PubMed records
TypeRecordsShare
Reviews1716.6%
Meta-analyses60.2%
Randomized controlled trials491.9%

Method: PubMed query "Hyaline Membrane Disease"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in respiratory medicine

Research on airway and lung disease mixes lung-function tests, symptom diaries, imaging and hospital records, so what was measured and in whom matters as much as the result. Many conditions here, such as asthma and COPD, vary between people and over time, and exposure studies (smoking, pollution, workplace dust) show association rather than proof of cause. Nothing on this page is advice about treatment or inhalers; anyone with breathing difficulty should seek care from a qualified clinician. Check how the condition was defined, the severity of the people studied and whether outcomes were symptoms, lung function or hospital admissions.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Neonatal respiratory distress in a reference neonatal unit in Cameroon: an analysis of prevalence, predictors, etiologies and outcomes
Tochie JN, Choukem SP, Langmia RN, Barla E, Koki-Ndombo P
2016Research article
Design not recorded in structured metadata
39cc by
PMID 27642489 · DOI · PMC5012800
Risk Factors of Respiratory Diseases Among Neonates in Neonatal Intensive Care Unit of Qena University Hospital, Egypt
Baseer KAA, Mohamed M, Abd-Elmawgood EA
2020Research article
Design not recorded in structured metadata
31cc by
PMID 32140431 · DOI · PMC7047767
Chest physiotherapy in preterm infants with lung diseases
Giannantonio C, Papacci P, Ciarniello R, Tesfagabir MG, Purcaro V, Cota F, et al.
2010Clinical trial
Design not recorded in structured metadata
26cc by
PMID 20868518 · DOI · PMC2955600
Clinical and Genetic Characteristics of COL2A1-Associated Skeletal Dysplasias in 60 Russian Patients: Part I
Markova T, Kenis V, Melchenko E, Osipova D, Nagornova T, Orlova A, et al.
2022Research article
Design not recorded in structured metadata
14cc by
PMID 35052477 · DOI · PMC8775336

Neonatal respiratory distress in a reference neonatal unit in Cameroon: an analysis of prevalence, predictors, etiologies and outcomes [1]

Research article Tochie JN, Choukem SP, Langmia RN, Barla E, Koki-Ndombo P · · 2016 · cited 39 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
IntroductionNeonatal respiratory distress (NRD) is a main cause of neonatal morbidity and mortality in developing countries.
Closing excerpt
Adequate follow-up of pregnancy and labor for timely intervention may improve the neonatal outcomes.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (192 words)

IntroductionNeonatal respiratory distress (NRD) is a main cause of neonatal morbidity and mortality in developing countries. Early detection of its risk factors and early treatment of its etiologies are major challenges. However, few studies in developing countries have provided data needed to tackle it. We aimed to determine the prevalence, predictors, etiologies and outcome of NRD in a tertiary health care centre of Cameroon.MethodsWe analyzed the hospital files of all newborns admitted to the Neonatal unit of Douala General Hospital from 1(st) January 2011 to 28(th) February 2013. NRD was diagnosed based on the presence of one or more of the following signs: an abnormal respiratory rate, expiratory grunting, nasal flaring, chest wall recessions and thoraco-abdominal asynchrony with or without cyanosis, in their files. Socio-demographic and clinical variables of newborns and their mothers were analyzed using logistic regression analysis.ResultsThe prevalence of NRD was 47.5% out of the 703 newborns studied. Acute fetal distress, elective caesarean delivery, APGAR score ConclusionNRD is a frequent emergency and causes high morbidity and mortality. Most of its risk factors and etiologies are preventable. Adequate follow-up of pregnancy and labor for timely intervention may improve the neonatal outcomes.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 27642489 · DOI · PMC5012800

Risk Factors of Respiratory Diseases Among Neonates in Neonatal Intensive Care Unit of Qena University Hospital, Egypt [2]

Research article Baseer KAA, Mohamed M, Abd-Elmawgood EA · · 2020 · cited 31 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundRespiratory diseases in newborns are considered major causes of neonatal morbidity and mortality especially in developing countries.
Closing excerpt
Respiratory distress syndrome carried the highest risk of mortality and TTN carried the highest survival rate.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (249 words)

BackgroundRespiratory diseases in newborns are considered major causes of neonatal morbidity and mortality especially in developing countries. Its causes are diverse and require early detection and management. This study aimed for detection of the prevalence and risk factors of respiratory diseases in addition to outcome among neonates admitted in neonatal intensive care unit.MethodsOur study was a prospective observational study that was undertaken at the neonatal intensive care unit of Qena University Hospital, Egypt from July 2017 to July 2018. Demographic and clinical data of newborns and their mothers were evaluated and tabulated.ResultsIn this period, 312 neonates were admitted to the neonatal intensive care unit, out of them 145 suffered respiratory diseases giving a prevalence of (46.5%), and (55.9%) were males. The mean neonatal age at admission was 4.33 ± 7.19 days and mean gestational age was 34.49 ± 3.31 weeks. The most common detected respiratory diseases were respiratory distress syndrome (RDS; 49.6%), transient tachypnea of newborn (TTN; 22%), neonatal pneumonia (17.2%) and meconium aspiration syndrome (MAS; 6.21%). Premature rupture of membrane (PROM), maternal diabetes and fetal prematurity had the highest risk factors for respiratory diseases occurrence in neonates. Neonatal mortality rate was 26.2%, mainly due to hyaline membrane disease and pneumonia.ConclusionRespiratory diseases constitute major part of total admission in neonatal intensive care unit especially RDS, TTN, pneumonia and MAS. Prematurity and maternal diabetes were the most important risk factors associated with respiratory diseases. Respiratory distress syndrome carried the highest risk of mortality and TTN carried the highest survival rate.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32140431 · DOI · PMC7047767

Chest physiotherapy in preterm infants with lung diseases [3]

Clinical trial Giannantonio C, Papacci P, Ciarniello R, Tesfagabir MG, Purcaro V, Cota F, et al. · · 2010 · cited 26 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundIn neonatology the role of chest physiotherapy is still uncertain because of the controversial outcomes.
Closing excerpt
ConclusionsOur experience, using the Vojta method, allows to affirm that this method is safe for preterm neonates, but further investigations are necessary to confirm its positive effects and to evaluate long-term respiratory outcomes.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (258 words)

BackgroundIn neonatology the role of chest physiotherapy is still uncertain because of the controversial outcomes.MethodsThe aim of this study was to test the applicability in preterm infants of 'reflex rolling', from the Vojta method, in preterm neonates with lung pathology, with particular attention to the effects on blood gases and oxygen saturation, on the spontaneous breathing, on the onset of stress or pain. The study included 34 preterm newborns with mean gestational age of 30.5 (1.6) weeks - mean (DS) - and birth weight of 1430 (423) g - mean (DS) -, who suffered from hyaline membrane disease, under treatment with nasal CPAP (continuous positive airways pressure), or from pneumonia, under treatment with oxygen-therapy. The neonates underwent phase 1 of 'reflex rolling' according to Vojta method three times daily. Respiratory rate, SatO2, transcutaneous PtcCO2 e PtcO2 were monitored; in order to evaluate the onset of stress or pain following the stimulations, the NIPS score and the PIPP score were recorded; cerebral ultrasound scans were performed on postnatal days 1-3-5-7, and then weekly.ResultsIn this population the first phase of Vojta's 'reflex rolling' caused an increase of PtcO2 and SatO2 values. No negative effects on PtcCO2 and respiratory rate were observed, NIPS and PIPP stress scores remained unmodified during the treatment; in no patient the intraventricular haemorrhage worsened in time and none of the infants developed periventricular leucomalacia.ConclusionsOur experience, using the Vojta method, allows to affirm that this method is safe for preterm neonates, but further investigations are necessary to confirm its positive effects and to evaluate long-term respiratory outcomes.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 20868518 · DOI · PMC2955600

Clinical and Genetic Characteristics of COL2A1-Associated Skeletal Dysplasias in 60 Russian Patients: Part I [4]

Research article Markova T, Kenis V, Melchenko E, Osipova D, Nagornova T, Orlova A, et al. · · 2022 · cited 14 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The significant variability in the clinical manifestations of COL2A1-associated skeletal dysplasias makes it necessary to conduct a clinical and genetic analysis of individual nosological variants, which will contribute to improving our understanding of the pathogenetic mechanisms and prognosis.
Closing excerpt
In the C-propeptide region, five novel variants leading to the development of unusual phenotypes of spondyloepiphyseal dysplasia have been identified.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (208 words)

The significant variability in the clinical manifestations of COL2A1-associated skeletal dysplasias makes it necessary to conduct a clinical and genetic analysis of individual nosological variants, which will contribute to improving our understanding of the pathogenetic mechanisms and prognosis. We presented the clinical and genetic characteristics of 60 Russian pediatric patients with type II collagenopathies caused by previously described and newly identified variants in the COL2A1 gene. Diagnosis confirmation was carried out by new generation sequencing of the target panel with subsequent validation of the identified variants using automated Sanger sequencing. It has been shown that clinical forms of spondyloepiphyseal dysplasias predominate in childhood, both with more severe clinical manifestations (58%) and with unusual phenotypes of mild forms with normal growth (25%). However, Stickler syndrome, type I was less common (17%). In the COL2A1 gene, 28 novel variants were identified, and a total of 63% of the variants were found in the triple helix region resulted in glycine substitution in Gly-XY repeats, which were identified in patients with clinical manifestations of congenital spondyloepiphyseal dysplasia with varying severity, and were not found in Stickler syndrome, type I and Kniest dysplasia. In the C-propeptide region, five novel variants leading to the development of unusual phenotypes of spondyloepiphyseal dysplasia have been identified.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 35052477 · DOI · PMC8775336

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Hyaline membrane disease [5]
    Farrell PM, Avery ME · Am Rev Respir Dis · 1975 · cited 236 times (Europe PMC)
  • Research article Surfactants: past, present and future [6]
    Halliday HL · J Perinatol · 2008 · cited 139 times (Europe PMC)
  • Research article Prematurity and the developing lung [7]
    Thurlbeck WM · Clin Perinatol · 1992 · cited 28 times (Europe PMC)
  • Research article Hyaline-membrane disease: therapy with constant lung-distending pressure [8]
    Chernick V · N Engl J Med · 1973 · cited 27 times (Europe PMC)
  • Research article Drug therapy of the fetus [9]
    Ward RM · J Clin Pharmacol · 1993 · cited 24 times (Europe PMC)
  • Research article Hyaline membrane disease [10]
    Reynolds EO · Am J Obstet Gynecol · 1970 · cited 20 times (Europe PMC)

References

  1. Tochie JN, Choukem SP, Langmia RN, Barla E, Koki-Ndombo P. Neonatal respiratory distress in a reference neonatal unit in Cameroon: an analysis of prevalence, predictors, etiologies and outcomes. . 2016. PMID 27642489 · DOI · PMC5012800
  2. Baseer KAA, Mohamed M, Abd-Elmawgood EA. Risk Factors of Respiratory Diseases Among Neonates in Neonatal Intensive Care Unit of Qena University Hospital, Egypt. . 2020. PMID 32140431 · DOI · PMC7047767
  3. Giannantonio C, Papacci P, Ciarniello R, Tesfagabir MG, Purcaro V, Cota F, et al.. Chest physiotherapy in preterm infants with lung diseases. . 2010. PMID 20868518 · DOI · PMC2955600
  4. Markova T, Kenis V, Melchenko E, Osipova D, Nagornova T, Orlova A, et al.. Clinical and Genetic Characteristics of COL2A1-Associated Skeletal Dysplasias in 60 Russian Patients: Part I. . 2022. PMID 35052477 · DOI · PMC8775336
  5. Farrell PM, Avery ME. Hyaline membrane disease. Am Rev Respir Dis. 1975. PMID 1093459 · DOI
  6. Halliday HL. Surfactants: past, present and future. J Perinatol. 2008. PMID 18446178 · DOI · PMC7104445
  7. Thurlbeck WM. Prematurity and the developing lung. Clin Perinatol. 1992. PMID 1526069 · DOI
  8. Chernick V. Hyaline-membrane disease: therapy with constant lung-distending pressure. N Engl J Med. 1973. PMID 4577904 · DOI
  9. Ward RM. Drug therapy of the fetus. J Clin Pharmacol. 1993. PMID 8227473 · DOI
  10. Reynolds EO. Hyaline membrane disease. Am J Obstet Gynecol. 1970. PMID 4984152 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Respiratory Distress SyndromeRespiratory Medicine
  • Bronchopulmonary DysplasiaRespiratory Medicine
  • Retinopathy of PrematurityEye, Ear, Nose and Throat
  • Pulmonary Alveolar ProteinosisRespiratory Medicine
  • Pulmonary AtelectasisRespiratory Medicine
  • Anti-Glomerular Basement Membrane DiseaseRespiratory Medicine

All 46 articles in Respiratory Medicine →

At a glance

2,609
PubMed records on this heading
1%
published since 2020
171
review articles
49
randomized trials
10
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Respiratory Distress SyndromeRespiratory Medicine
  • Bronchopulmonary DysplasiaRespiratory Medicine
  • Retinopathy of PrematurityEye, Ear, Nose and Throat
  • Pulmonary Alveolar ProteinosisRespiratory Medicine
  • Pulmonary AtelectasisRespiratory Medicine

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support